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Hypercholesterolemia-induced 
increase in plasma oxidized LDL abrogated 
pro angiogenic response in kidney grafts
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Abstract 
Background: Renal transplantation is increasingly associated with the presence of comorbidity factors such as dys-
lipidemia which could influence the graft outcome. We hypothesized that hypercholesterolemia could affect vascular 
repair processes and promote post-transplant renal vascular remodeling through the over-expression of the anti-
angiogenic thrombospondin-1 interacting with vascular endothelial growth factor-A levels.
Methods: We tested this hypothesis in vitro, in vivo and in a human cohort using (1) endothelial cells; (2) kidney 
auto-transplanted pig subjected (n = 5) or not (n = 6) to a diet enriched in cholesterol and (3) a renal transplanted 
patient cohort (16 patients).
Results: Cells exposed to oxidized LDL showed reduced proliferation and an increased expression of thrombospon-
din-1. In pigs, 3 months after transplantation of kidney grafts, we observed a deregulation of the hypoxia inducible 
factor 1a—vascular endothelial growth factor-A axis induced in cholesterol-enriched diet animals concomitant with 
an overexpression of thrombospondin-1 and a decrease in cortical microvessel density promoting vascular remod-
eling. In patients, hypercholesterolemia was associated with decreased vascular endothelial growth factor-A plasma 
levels during early follow up after renal transplantation and increased chronic graft dysfunction.
Conclusions: These results support a potential mechanism through which a high fat-diet impedes vascular repair 
in kidney graft and suggest the value of controlling cholesterolemia in recipient even at the early stage of renal 
transplantation.
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Background
In renal transplantation, the increase of older recipients 
due to population ageing amplifies the current organ 
shortage, promoting a raise in the mean donor age. These 
increases induce a higher prevalence of comorbidity fac-
tors which could influence renal graft outcome. During 
the transplantation process, kidney grafts are unavoida-
bly exposed to ischemia–reperfusion (I/R) injury. The key 
role played by I/R in defining the balance between regen-
erative or detrimental pathways and irreversibly pro-
gramming graft outcome imply that it is of paramount 
importance to determine the factors or co-morbidity fac-
tors which could early interact with graft viability.
Risk factors for cardiovascular diseases such as dia-
betes, hypertension and elevated plasmatic low-density 
lipoprotein (LDL) levels are well documented in renal 
diseases progression and also in transplantation or renal 
artery stenosis injury [1]. The high prevalence of dys-
lipidemia combined with the use of older donors and 
with the hyperlipidemic effects of immunosuppressors 
strengthens the link between hypercholesterolemia and 
kidney transplantation [2, 3]. Thus, hyperlipidemia in the 
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recipient is of greater importance related to calcineurin 
or mTOR inhibitor exposure given the subsequent expo-
sure length of the graft to the recipient milieu. In general, 
hypercholesterolemia is associated with increased sys-
temic levels of oxidized low density lipoproteins (OxLDL) 
well known to be involved in endothelial cell dysfunction 
[4, 5]. Renal microcirculation, one of the critical targets 
of I/R injury, plays a crucial role in the early regenera-
tion phase but also in the extension of chronic renal dis-
ease through a complex interplay between proliferation, 
regeneration and capillary loss [6–8]. In healthy organs, 
vascular endothelial cells are protected from moderate 
injury by the release of autocrine signaling molecules 
such as vascular endothelial growth factor-A (VEGF-A) 
[9]. However, endothelial damage induced by I/R affect 
this regenerative response [10, 11].
Previously, Cui et al. reported the role of thrombospon-
din-1 (TSP-1) as an important mediator for high fat-diet 
induced kidney dysfunction in mice characterized by 
macrophage infiltration and fibrosis development [12]. 
TSP-1 is also involved in numerous detrimental pro-
cesses induced by kidney I/R, but little is known about 
this effect in kidney graft outcome and the link between 
TSP-1 and OxLDL [13]. TSP-1 is a matricellular glyco-
protein that interacts with different receptors and has 
multiple functions including promotion of clot forma-
tion or fibrosis and is also well-known as an inhibitor of 
angiogenesis by different mechanisms such as interacting 
with VEGF-A levels or modulating the NO availability 
which may prevent kidney repair [14].
This study is aimed at determining the role of hyper-
cholesterolemia and particularly oxidized LDL (OxLDL) 
in early vascular regenerative processes occurring after 
I/R injury in renal transplantation that are distinct from 
the chronic injury of atherosclerosis induced by dyslipi-
demia. We hypothesized that OxLDL could impede pro-
tective angiogenesis mechanism induced by I/R through 
the stimulation of TSP-1 expression and its effects on 
VEGF-A production.
Methods
In vitro incubation of OxLDL on human aortic endothelial 
cells
OxLDL’s effects were evaluated in Human Aortic 
Endothelial Cells (HAEC) treated with culture medium 
supplemented or not with OxLDL (25 μg/mL) for 24 h. 
Briefly, HAEC obtained from Gibco (Saint Aubin, 
France) were cultured in Medium 200 (M200, Gibco) 
supplemented with 10% fetal bovine serum (Invitro-
gen, Saint Aubin, France) in a humidified atmosphere 
at 5%  CO2 and 37 °C. Cells were serum starved for 12 h 
and then treated. After treatment, condition media was 
removed and cells were collected to western blotting 
analysis for protein expression of TSP-1 (1/500, Santa 
Cruz Biotechnology, Santa Cruz, California, USA), 
ADAMTS-1 (1/500, Santa Cruz Biotechnology, Santa 
Cruz, California, USA), PhosphoVEGF-R2 (1/1000, Cell 
signaling, Leiden, Netherlands), and VEGF-R2 (1/1000, 
Cell signaling, Leiden, Netherlands). TSP-1 levels in 
the supernatant were quantified by ELISA kit (RnD 
Systems, Minneapolis, USA). Flow cytometry analysis 
was used for alpha5beta3 integrin expression on HAEC 
cells (1/100, Millipore, Billerica, Massachusetts, USA). 
The effect of recombinant human TSP-1 (0.5 µg/ml; RD 
System, Lille, France) on alpha5beta3 integrin protein 
expressions was investigated. Cell proliferation was 
assessed by the BrDU assay (Cell Proliferation ELISA, 
BrdU, Roche, USA) following the manufacturer’s 
guidelines in cells treated with culture medium sup-
plemented or not with OxLDL for 24 h in presence of 
recombinant VEGF (Gibco) and SiRNa targeted TSP-1 
(Qiagen, Courtaboeuf, France).
Animal model and surgical procedures
Male Large White pigs (Sus Scrofa) were fed with a 
standard or a high-fat diet (standard diet + 20% lard 
and 2% cholesterol) immediately after weaning and 
maintained until euthanasia, i.e. 3  months after trans-
plantation as previously described in previous stud-
ies [1, 15]. Renal auto-transplantation model was 
performed 2  months after weaning as previously 
described in accordance with the institutional commit-
tee for the use and care of laboratory animals (CEEA 
Poitou–Charentes CE2012-4) [16]. Briefly, the left kid-
ney was removed, flushed with 300 ml of UW preserva-
tion solution and preserved at 4 °C in the same solution 
in static conditions for 24 h. On the day of transplanta-
tion, the right kidney was removed and the left kidney 
grafted mimicking the nephron mass in transplanted 
situation. Two experimental groups were studied: Nor-
mal diet: transplanted kidneys collected 3 months after 
surgery from animals fed a standard diet (n = 6), High-
fat diet: transplanted kidneys collected 3 months after 
surgery from animals fed a high-fat diet (n = 5). One 
transplanted high-fat diet pig died before completion 
of the study due to surgical complications and was not 
included in data analysis. Urinary and plasma creati-
nine or proteinuria were measured using an automatic 
analyzer (Modular, Roche Diagnostic, Meylan, France). 
Creatinine clearance was calculated by the formula: 
(Urinary volume × Urinary creatinine level)/plasma 
creatinine level. Peripheral blood was collected before 
kidney transplantation, at 3, 7  days and 1, 3  months 
after reperfusion. Urines were collected at 3, 7 days and 
1, 3 months after reperfusion.
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Western blotting, immunohistochemistry and standard 
light microscopy
These studies were performed on renal tissue from graft 
kidneys 3  months after transplantation to assess the 
mechanisms responsible for formation and maintenance 
of the renal microvasculature and vascular remodeling. 
We investigated by standard western blotting protocols 
[17] pro- angiogenic pathways with specific antibodies 
against hypoxia inducible factor 1a (HIF1a, 1/500, BD 
Biosciences, San Jose, California, USA), VEGF (1/500, 
Santa Cruz Biotechnology), Stromal cell-Derived Factor-1 
(SDF-1, 1/1000, Abbiotech, San Diego, California, USA), 
factors involved in endothelial cells proliferation and 
migration: matrix metalloproteinase 9 (MMP-9, 1/1000, 
Millipore), alpha5beta3 integrin (1/1000, Millipore), and 
anti-angiogenic factor: A Disintegrin And Metallopro-
teinase with Thrombospondin Motif-1 (ADAMTS-1, 
1/200, Santa Cruz Biotechnology). Loading controls were 
β actin (1/20,000, Sigma, St Louis, Missouri, USA). Pro-
tein bands were revealed and intensities were quantified 
using AlphaEase FC software (Alpha Innotech Corpora-
tion, San Leandro, CA). Staining evaluations using semi-
quantitative analyses on cortex samples was performed 
as previously described and examined under blind con-
ditions by a pathologist and a nephrologist [18]. Briefly, 
paraffin sections were used for tubulo-interstitial fibrosis 
evaluation by Masson trichrome staining. Alpha-smooth 
muscle actin (αSMA, 1/100, Dako, Stockholm, Sweden) 
expression was assessed by diamino benzidine staining. 
The microvascular media-to-lumen ratio was measured 
in αSMA-positive macrovessels under 500  µm in diam-
eter. Tubular atrophy was assessed by Hematoxylin–
Eosin–Safran (HES) staining with previously published 
scoring [19]. Frozen sections were used for TSP-1 (1/100, 
Santa Cruz Biotechnology), VEGF (1/100, Santa Cruz 
Biotechnology), HIF1a (1/100, BD Biosciences) expres-
sions in cortical section by immunofluorescence as well 
as ED-1 antigen marker of macrophages and monocytes 
(1/100, AbD Serotec, Oxford, UK).
Apoptotic signals
Apoptotic renal cells were characterized by the TUNEL 
method using the DeadEnd Fluorometric TUNEL system 
(Promega, Fitchburg, Massachusetts, USA) as previously 
shown [20].
Real‑time quantitative PCR
We used RNA extraction kit (Qiagen, Courtaboeuf, 
France). Genomic DNA was removed using DNA-free 
kit (Applied Biosystems, Foster City, California, USA) 
and first-strand reverse transcription (Applied) was per-
formed. Real-Time PCR assays were performed on an 
ABI Prism 7300 (Applied) with porcine primers adapted 
for VEGF and TSP-1 mRNA expressions (Additional 
file 1: Table S1).
Tissue preparation, acquisition and analysis of images 
by high resolution micro‑computed tomography
Three months post-transplant at the time of sacrifice, 
the kidney graft was removed and perfused with a saline 
solution containing 5000  IU/L of heparin. Then, the 
saline solution was replaced by an intravascular radio-
opaque silicone polymer (Microfil MV122; Flow Tech, 
Carver, Massachusetts, USA). The kidney was immersed 
in formalin solution at 4 °C and a cylinder biopsy (diam-
eter: 1  cm; depth: 1.5  cm) of the polymer-filled kidney 
was performed and encased in paraffin. High resolution 
micro-computed tomography scans were performed, fol-
lowed by image reconstructions using specific algorithm 
[21]. The average diameter and spatial density of corti-
cal vascular segments of microvessels were calculated as 
previously described [17, 22] and the spatial density clas-
sified according to diameter as small (< 40 µm), medium 
(40–80 µm), large (80–120 µm) or very large (> 120 µm) 
vessels.
Patients
A prospective cohort study was conducted on 16 kidney 
transplant patients at the Transplant Unit of the Poitiers 
University Hospital between January 2010 and June 2010. 
Adult recipients of a first or second kidney transplant 
were eligible for enrollment and patients with preemp-
tive graft, infectious complications and early acute 
graft rejection have been excluded. The blood samples 
were taken during the normal follow-up of the patient, 
anonymized and since the study did not require addi-
tional blood sampling, an approval from an ethics com-
mittee was not required under French law according 
to the article L.1121-1 of the public health code. Writ-
ten informed consents were obtained from each patient 
according to the Declaration of Helsinki. We classified 
patients in 2 groups related to the plasma cholesterol 
levels using a threshold of 1.80  g/L. Renal function was 
assessed by urinary protein excretion and eGFR accord-
ing to the simplified modification of diet in renal disease 
formula MDRD. Peripheral blood was collected by veni-
puncture at day 0 (D0) before kidney transplantation, 1, 
3, 7 and 14 days (respectively D1, D3, D7 and D14), 1, 3 
and 12 months after surgery. Plasma samples were stored 
at − 80  °C prior to protein quantification by ELISA for 
OxLDL (Mercodia, France), and VEGF-A (RD System).
Statistics
Results are shown as means ± SD. We used a student 
t-test for two-group comparisons or a Mann–Whitney 
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test when the variance was not equal between the groups. 
For multiple group comparison, we used Kruskal–Wal-
lis test. Fisher’s exact test was used for statistical analysis 
of proportions. Statistical significance was accepted for 
p < 0.05.
Results
The inhibition of endothelial cells proliferation induced 
by OxLDL is mediated by TSP‑1
OxLDL-enriched culture medium induced the expres-
sion of ADAMTS-1 in HAEC and promoted the increase 
of TSP-1 secretion in supernatant without effect on 
phosphorylation of VEGF-R2 (Fig.  1a, c). Alpha5beta3 
integrin expression on HAEC, marker of endothelial cell 
proliferation, was decreased in both conditions: in cul-
ture medium enriched with OxLDL or supplemented 
with TSP-1 human recombinant protein (Fig. 1b). Inter-
estingly, SiRNA targeted TSP-1 (Additional file 2: Figure 
S1) limited the inhibition of cell proliferation induced 
by OxLDL in presence of VEGF underlining the role of 
TSP-1 in these inhibited conditions (Fig. 1d).
High‑fat diet reduces pro‑angiogenic pathways in renal 
auto‑transplanted pig
In a clinical relevant porcine model, as previously 
described, hyperlipidic diet induced an increase of 
plasma cholesterol level in the last part of the fol-
low up even if OxLDL plasmatic levels were signifi-
cantly elevated at the day of surgical procedure and 
at 3  months post-transplantation [15]. As previously 
reported, only high-fat diet was associated with an 
increased proteinuria at 1 and 3  months while both 
experimental conditions, with or without high-fat 
diet, induced similar kinetics for creatinine clearance 
(Table  1) [15]. The effects of OxLDL on regenerative 
vascular processes suggested by our in  vitro results 
were further assessed by measuring the expressions of 
proteins involved in these pathways at 3 months post-
reperfusion. The hypoxic pathway mediated by HIF1a 
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Fig. 1 The inhibition of endothelial cells proliferation induced by OxLDL is mediated by TSP-1. OxLDL incubation induced an increase of ADAMTS-1 
expression in HAEC without effect on TSP-1 and PhosphoVEGF-R2 protein expression (a; N = 3). Alpha5beta3 integrin expression on HAEC was 
reduced by OxLDL and human recombinant TSP-1 (b; N = 3). OxLDL enriched culture medium induced an increases secretion of TSP-1 by HAEC (c, 
N = 3). The inhibition of VEGF-proliferation cells induced by OxLDL was limited by SiRNA targeted TSP-1 (D, N = 4)
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well known to promote VEGF production was abro-
gated by the high-fat diet. Dyslipidemic pigs exhib-
ited an increased expression of HIF1a in kidney grafts 
3 months after while VEGF-A expression remained sta-
ble or even decreased when assessed by western blot-
ting and immunohistochemistry respectively (Figs. 2, 3, 
4a, b, Table  2, Additional file  3: Figure S2, Additional 
file 4: Figure S3). In addition, high-fat diet increased the 
expression of ADAMTS-1 (Fig. 4a) known as an activa-
tor of the TSP-1 pathway and decreased the expression 
of proteins involved in endothelial cell proliferation 
and migration such as SDF-1 (Fig.  4b). A trend was 
observed for MMP-9 and alpha5beta3 integrin (Fig. 4b).
TSP‑1 pathway is activated by high‑fat diet in kidney graft
To investigate the role of TSP-1 in the inhibition of the 
HIF1a pro-angiogenic pathways induced by hyperlipidic 
diet, we assessed TSP-1 expression in kidney graft. We 
observed in the high-fat diet group an increased protein 
expression of TSP-1 (Fig.  5; Table  2, Additional file  5: 
Figure S4). These results observed by immunohistologi-
cal studies showed an elevated staining of TSP-1 in the 
interstitium, tubules and glomerulus in high-fat diet 
group but not significant difference in glomerulus pari-
etal cell (Table  2). High-fat diet did not affect VEGF-A 
and TSP-1 mRNA expressions indicating rather a post-
transcriptional regulation of these pathways (Additional 
file 6: Figure S5).
High‑fat diet induces vascular and tissue remodeling 
in kidney graft
The increase of macrovascular media-to-lumen ratio 
indicated an intensive vascular remodeling in high-fat 
diet group compared to normal group (Fig. 6A). In addi-
tion, tubular atrophy was increased suggesting deleteri-
ous mechanism induced by hyperlipidic diet resulting 
in non functional fibrous tissue development assessed 
by Masson trichrome staining (Fig.  6B, C; Table  2) as 
Table 1 Summary table of  kidney function and  blood 
metabolites of  transplanted animals fed either  a  normal 
or  a  high-fat diet maintained for  3  months after  surgery 
(M3)
Values are mean ± SD
* p < 0.05 vs. normal diet, n = 5–6 in each group
D0 D3 D7 M1 M3
Creatinine clearance (ml/min)
 Normal diet / 7.8 ± 7.5 22.1 ± 3.3 71.9 ± 22.3 64.5 ± 35.3
 High-fat diet / 8.6 ± 14.3 24.7 ± 26.7 61.4 ± 22.3 58.5 ± 26.1
Urinary ratio protein/creatinine (mg/mmol)
 Normal diet / / / 124 ± 5 108 ± 4
 High-fat diet / / / 236 ± 12* 183 ± 9*
High-fat Diet 
DAPI HIF 1a Merge 
DAPI HIF 1a Merge 
Normal Diet 
Fig. 2 High-fat diet increases HIF1a expression in porcine auto-transplanted kidneys. Immunofluorescence staining in cortex tissue for HIF1a in 
high-fat or normal diet groups, 3 months after renal auto-transplantation surgery. Scale bars represent 100 µm (magnification ×40; n = 5 in each 
group)
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High-fat Diet 
DAPI VEGF Merge 
DAPI VEGF Merge 
Normal Diet 
Fig. 3 High-fat diet reduces VEGF expression in porcine auto-transplanted kidneys. Immunofluorescence staining in cortex tissue for VEGF in 
high-fat or normal diet groups, 3 months after renal auto-transplantation surgery. Scale bars represent 100 µm (magnification ×40; n = 5 in each 
group)
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Fig. 4 High-fat diet reduces pro-angiogenic pathways in porcine auto-transplanted kidneys. Expression by western blotting of proteins involved in 
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previously suggested [15]. High resolution micro-com-
puted tomography showed a decrease of the density of 
vascular segments with a diameter inferior to 40  µm in 
the hyperlipidic diet kidney grafts, indicating a high 
microvessel injury (Fig.  6D). These results were sup-
ported by aminopeptidase staining indicating a decrease 
of capillary density in hyperlipidic diet group (Additional 
file  7; Additional file  8: Figure S6). In the cortex, this 
experimental group exhibited a reduction of the aver-
age vascular segment diameter supporting a vascular 
remodeling stimulated by high-fat diet (Fig.  6D). These 
injuries were associated with a pro-inflammatory milieu 
supported by ED1-positive cells infiltration significantly 
elevated in dyslipidemic pigs as well as apoptosis stimula-
tion (Fig. 7A, B). 
Hypercholesterolemia the day of surgery affects VEGF‑A 
secretion and promotes chronic graft dysfunction 
in patients
This single-center study enrolled a total of 16 Cau-
casian renal transplant recipients. Characteristics of 
recipients and renal transplant allograft donors are 
listed in Table  3. All patients received a kidney graft 
from deceased donors. Using a threshold of 1.80  g/L 
of plasma cholesterol level, the day before renal trans-
plantation, we classified patients in hyper or normo-
cholesterolemic groups (Fig. 8a). There was no patient 
death and two grafts loss during the follow up (1 in 
each group). Plasma OxLDL measurement in the blood 
samples collected before surgery showed a high level in 
Table 2 Summary table of  semi-quantification of  kidney 
stainings in  transplanted animals fed either  a  normal 
or  a  high-fat diet maintained for  3  months after  surgery 
(M3)
Values are mean ± SD
* p < 0.05 vs. normal diet, n = 5 in each group
Normal diet High‑fat diet
Renal HIF1a expression by field
 Positive tubules 5.40 ± 0.53 11.52 ± 0.58*
 Positive cells 5.00 ± 0.63 11.88 ± 1.00*
 Surface area (%) 6.00 ± 0.35 13.70 ± 0.91*
Renal VEGF-A expression by field 
positive vessels
6.98 ± 0.47 2.78 ± 0.32*
Renal TSP-1 expression by field
 Positive glomerulus parietal cell 2.54 ± 0.28 2.72 ± 0.35
 Positive glomerulus 1.73 ± 0.29 3.12 ± 0.28*
 Positive tubules 2.69 ± 0.47 9.03 ± 1.39*
 Interstitium staining (%) 4.00 ± 0.63 16.83 ± 0.70*
 Tubular atrophy (%) 6.35 ± 1.30 16.80 ± 0.74*
 Trichrome staining (%) 6.31 ± 0.78 16.81 ± 0.47*
Normal Diet 
DAPI TSP-1 Merge 
High-fat Diet 
DAPI TSP-1 Merge 
Fig. 5 High-fat diet promotes TSP-1 expression in porcine auto-transplanted kidney. TSP-1 expression by immunofluorescence staining was 
assessed in cortical part from the kidney grafts subjected or not to a hyperlipidic diet. Scale bars represent 100 µm (Magnification ×40; n = 5 in 
each group)
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the hypercholesterolemia group but not reached statis-
tical difference (p = 0.061; Fig.  8b). Interestingly, we 
observed a decrease of plasmatic VEGF-A level, 1 day 
after surgery in the hypercholesterolemia group which 
reached statistical significance at D3 and returned 
to basal level from D7 (Fig.  8c). The levels of plasma 
TSP-1 before surgery were increased in the hypercho-
lesterolemia group (Additional file 9: Figure S7). Esti-
mated glomerular filtration rate (eGFR) was similar in 
both groups up to 3  months post-surgery. However, 
1 year after transplantation, the eGFR was significantly 
reduced in the hypercholesterolemia group (Table  3) 
and urinary protein excretion increased (Table 3). 
Discussion
Organ shortage in renal transplantation has two major 
consequences: (1) it pushes transplantation centers to 
use organs obtained from older donors; (2) it increases 
the time spent on the waiting list, therefore increasing 
the average recipient age. This type of donors/recipi-
ents is linked with age-related co-morbidity factors such 
as hypertension or hypercholesterolemia, negatively 
affecting the transplantation outcome and leading back 
patients to dialysis [23]. The identification of involved 
mechanisms could improve the management of recipient 
in these conditions and promote new therapeutic strate-
gies. Previously, Cui et al. reported for the first time that 
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TSP-1 is upregulated in the kidney from diet-induced 
obese mice with marked accumulation of TSP-1 in the 
glomeruli mesangium and tubular system [12]. They also 
demonstrated that TSP-1 deletion protects mice from 
obesity-induced renal fibrosis [12]. This detrimental 
effect was also observed in a syngeneic rat renal trans-
plantation model. Briefly, a CD47 monoclonal antibody, 
which blocks the interaction between the ligand TSP-1 
and its receptor CD47, used during the donor kidney 
perfusion, induced a marked improvement in post trans-
plant survival [24]. These results were also observed in 
a renal ischemia reperfusion injury model [25]. In this 
study, we investigated the early effects of high-fat diet 
on pro-angiogenic pathway inhibition and TSP-1 expres-
sion in a porcine model of renal auto-transplantation 
with high clinical relevance. This allowed us to focus on 
I/R injury in the absence of any allogeneic response and 
easily extrapolate the results to human as porcine and 
human kidneys have the same multilobular architecture 
and similar cortical microcirculation [26]. Hypercholes-
terolemia is associated with increased circulating levels 
of OxLDL [4]. These oxidized lipoproteins are involved 
in endothelial cell dysfunction [5], the first cell type sub-
jected to I/R injury in organ transplantation. However, 
vascular endothelial cells are protected by the release of 
autocrine signaling molecules such as the pivotal VEGF-
A and are well known to proliferate, migrate and regener-
ate the injured tissue [9]. In a previous study, Sunitinib, a 
tyrosine kinase inhibitor which inhibits both VEGF and 
PDGF receptors, prevents chronic rejection changes in 
experimental kidney transplantation and preserved sig-
nificantly renal graft function after transplantation high-
lighting the role of VEGF in early kidney graft function 
[27].
In the first part of this study, we investigated in 
endothelial cell model, the effects of OxLDL incubation 
on TSP-1 expression. We reported, for the first time, 
that OxLDL promotes TSP-1 secretion in endothe-
lial artery cells according to the increase expression of 
ADAMTS-1 and decreases the expression of alpha5beta3 
integrin known as an integrin required for angiogenesis 
and endothelial proliferation [28]. TSP-1 uses multiple 
pathways to modulate endothelial cell migration [29]. 
TSP-1 is known as a natural antagonist of alpha5beta3 
integrin through alpha5beta3 ligation and it has been 
shown to negatively regulate focal adhesion formation 
on fibronectin, suggesting that integrin function may 
be impaired [29]. These results suggest a repressive role 
of OxLDL production stimulated by hyperlipidic diet 
on angiogenesis through a TSP-1-dependent pathway 
underlining by the SiRNA experiment. Renal I/R induces 
regenerative processes such as angiogenesis which could 
be affected by OxLDL permanent production. Since our 
in vitro model relies on the culture on one cell type and 
is far to mimic the complexity of the kidney physiology, 
we decided to further test our hypothesis in our porcine 
a b 
Normal Diet
High-fat Diet
0
2
4
6
8
10
ED
1 
 p
os
i
ve
 c
el
ls 
by
  fi
el
d 
* 
TU
N
EL
 p
os
i
ve
 c
el
ls 
by
 fi
el
d 
a b 
* 
0.0
1.0
2.0
3.0
4.0
5.0
6.0
A B
Fig. 7 High-fat diet promotes apoptosis and macrophage infiltration in porcine auto-transplanted kidneys. Apoptotic cell death by TUNEL positive 
cell staining (A, scale bars represents 30 µm) and inflammatory ED1 positive cells infiltrated in graft by immunofluorescence staining (B, scale bars 
represents 40 µm) in normal diet (a) or high-fat (b) groups, 3 months after renal auto-transplantation surgery. *p < 0.05 vs. normal diet group; n = 5 
in each group
Page 10 of 14Kerforne et al. J Transl Med           (2019) 17:26 
model of renal auto-transplantation modulated only by 
the effect of the diet.
In previous studies, it has been shown that high-fat 
diet affects renal VEGF-A protein expression and impairs 
microvascular structures in native porcine kidney with-
out ischemic insults [30, 31]. This aspect is well docu-
mented and suggests that high-fat diet in transplant 
condition could affect pro-angiogenic processes mediated 
by VEGF-A. We exclusively focused this study on the role 
of high-fat diet in early vascular regenerative processes 
after an I/R injury in renal transplantation and excluded 
the effect of high-fat diet in native kidney since it was 
previously reported [30, 31]. In pigs fed with a high-fat 
diet beginning from weaning up, we previously reported 
an increase in plasma levels of OxLDL at the day of sur-
gery and at 3 months after transplantation [15]. This later 
increase was concomitant with a rise of total cholesterol 
levels. The discrepancy between plasma cholesterol and 
OxLDL levels the day of surgery could be explained by 
the fast required before surgery and underlined the role 
of high levels of plasma OxLDL during the early step of 
reperfusion. During follow up, renal function assessed 
by creatinine clearance was similar in both groups. This 
monitoring window for 3 months might be too short to 
observe significant differences in graft function. How-
ever, we observed a significant elevated proteinuria in 
high-fat diet group at 3  months post-transplantation 
which is described as a pivotal time point to investigate 
tissue and vascular remodeling and pro-angiogenic path-
ways [10, 17].
Renal tissue ischemia is one crucial factor in the devel-
opment and progression of chronic kidney disease in 
general. It is known that HIF1a expression is increased 
in area of severe fibrosis as observed in high-fat diet 
group indicated by Masson trichrome staining [9]. 
Decreased oxygen tension activates the stabilization of 
HIF1a, inducing a large range of pro-survival responses 
such as VEGF-A expression [32]. However, in this study, 
high-fat diet promotes a HIF1a stabilization without 
observed transcriptional effects on VEGF-A expression. 
Table 3 Patient characteristics
Values are mean ± SD
* p < 0.05 vs. normocholesterolemia
a eGFR: estimated glomerular filtration rate according to the MDRD formula (mL/min/1.73 m2)
Normocholesterolemia Hypercholesterolemia
Donors Donors
Age (years) 43 ± 9 53 ± 11
Traumatic death (%, n) 29 (2) 33 (3)
Hemorrhagic and ischemic stroke (%, n) 71 (5) 67 (6)
Anastomosis time (min) 42 ± 12 43 ± 9
Cold ischemia time (min) 888 ± 87 870 ± 180
eGFRa 81 ± 8 81 ± 6
Recipients Recipients
Number 7 9
Age (years) 45 ± 15 50 ± 14
Male gender (%, n) 86 (6) 56 (5)
Dialysis duration (months) 16 ± 9 6 ± 13*
Current smoker (%, n) 71 (5) 22 (2)*
Diabetes mellitus (%, n) 14 (1) 0 (0)
Hypertension (%, n) 86 (6) 78 (7)
Statin (%, n) 57 (4) 44 (4)
Cholesterolemia the day before surgery (mmol/L) 3.80 ± 0.54 6.04 ± 1.08*
Cholesterolemia at 3 months (mmol/L) 4.80 ± 0.47 5.78 ± 1.48
Cholesterolemia at 6 months (mmol/L) 4.32 ± 1.13 4.91 ± 1.19
Cholesterolemia at 12 months (mmol/L) 4.72 ± 1.09 5.10 ± 0.50
eGFRa at 1 month 48 ± 17 45 ± 25
eGFRa at 3 months 53 ± 23 50 ± 18
eGFRa at 12 months 64 ± 13 44 ± 13*
Urinary ratio protein/creatinine (mg/mmol) at 3 month 31.4 ± 21.2 73.9 ± 42.5
Urinary ratio protein/creatinine (mg/mmol) at 12 month 16.7 ± 5.2 78.6 ± 80.4*
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In addition, high-fat diet reduced the pro-angiogenic 
capacity of kidney graft as shown by the repressed 
expressions of SDF-1 and VEGF-A proteins [9, 28, 33]. 
Taken together, these results suggest an anti-angiogenic 
effect of hyperlipidic diet that could be mediated by TSP-
1. Neovascularization induced by angiogenic factors 
is counterbalanced by the effects of angiogenic inhibi-
tors, such as TSP-1, a glycoprotein expressed at very 
low levels in the healthy renal cortex and upregulated 
during some renal diseases [12]. Thakar et al. previously 
reported that TSP-1 null mice exhibited a significant 
protection against renal ischemia supporting the fact 
that TSP-1 acts as a regulator of ischemic damages in 
the kidney [34]. TSP-1 inhibits angiogenesis through its 
direct effects on endothelial cells and indirect effects on 
growth-factor mobilization and activation [9]. To inves-
tigate the role of TSP-1 in our conditions, we evaluated 
its expression in grafts. Hyperlipidic diet induced an 
over-expression of TSP-1 protein, 3  months after trans-
plantation, in glomerulus, intensively marked in tubules 
and interstitium without mRNA expression change sug-
gesting a post-transcriptional regulation of TSP-1. This 
hypothesis was supported by ADAMTS-1 overexpres-
sion. Indeed, ADAMTS-1 is a soluble matrix metallopro-
tease molecule that inhibits angiogenesis by mechanisms 
that may involve direct sequestration of VEGF or release 
activation of anti-angiogenic thrombospondin-derived 
peptides such as TSP-1 [35, 36]. ADAMTS-1 was already 
described to be enhanced in rat proximal tubules after 
I/R [37] and also in atherosclerosis with macrophage 
invading the tissue [38]. We observed an increase of 
ED1-positive macrophages infiltrating interstitium in 
high-fat diet group, in accordance with the elevated level 
expression of ADAMTS-1. The significant increase of 
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inflammatory ED-1 positive macrophages in the inter-
stitium of kidney grafts exposed to high OxLDL levels 
was linked with the profibrotic milieu associated with 
tubular atrophy. In addition, in this group, TSP-1 could 
stimulate apoptotic process as suggested by the TUNEL 
staining increase [39]. In order to investigate the con-
sequences of these pro-inflammatory and regenerative 
pathways on vascular remodeling, we characterized the 
cortical microvascularization damages. High-fat diet 
increased the microvascular rarefaction induced by I/R 
injury in our renal transplantation model particularly 
for small vascular segments with diameter inferior to 
40 µm according to the decrease of capillary density and 
the inhibition of pro-angiogenic pathways observed. In 
addition, the decrease of vascular segment diameter sup-
ported a vascular remodeling according to the high ratio 
of media-to-lumen and fibrosis development.
In order to test the relevance of our results in human 
transplantation, we investigated the effect of hypercho-
lesterolemia on the systemic levels of the pivotal angio-
genic vascular growth factor: VEGF-A in the short-term 
follow up after renal transplantation. We observed that 
recipients with high levels of cholesterol the day of sur-
gical procedure, exhibited a decrease of plasmatic levels 
of VEGF-A during the first 3  days after transplantation 
suggesting a reduction of the regenerative processes in 
the graft. In addition, in this preliminary study, we under-
lined that the level of cholesterolemia the day of surgical 
procedure could affect graft outcome as indicated by the 
decrease of filtration function (eGFR) and by the increase 
of urinary protein excretion in hypercholesterolemic 
patient, 1 year after reperfusion. Although patient char-
acteristics were similar in both groups, we should notice 
that other confounding factors could be involved in these 
differences such as immunosuppressive therapies. Fur-
ther analyses will be necessary to support the correlation 
between the increase of TSP-1 levels observed in plasma 
recipient before surgery and its role on plasma VEGF-A 
levels early after transplantation.
Conclusions
Taken together, these results support that: (1) OxLDL are 
involved in abrogation of regenerative capacity of kidney 
grafts (2) TSP-1 is overexpressed in porcine kidney grafts 
exposed to high-fat diet and associated to a repression of 
pro angiogenic pathways, (3) high-fat diet induces micro-
vascular rarefaction and vascular remodeling and (4) 
hypercholesterolemic patients have an early decrease of 
VEGF-A plasma levels after transplantation surgery.
In conclusion, our study underlines the impact of a 
short term exposition to high-fat diet on the early stage 
of regenerative processes after renal transplantation, 
distinct from the chronic injury of atherosclerosis 
induced by dyslipidemia. In addition, high-fat diet or 
dyslipidemia in recipient of kidney graft could affect 
organ outcome identifying TSP-1 as a therapeutic tar-
get of interest and emphasizing the need to better 
control either cholesterol or OxLDL plasma levels in 
recipient at the early stage of renal transplantation.
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